Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials

Published:2021-05-06 Issue:8 Volume:23 Page:1806-1822
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Bray Jonathan J. H.¹²^ORCID,Foster‐Davies Harri¹^ORCID,Salem Ahmed²³^ORCID,Hoole Amy L.¹^ORCID,Obaid Daniel R.²^ORCID,Halcox Julian P. J.²^ORCID,Stephens Jeffrey W.¹³^ORCID

Affiliation:

1. Department of Diabetes and Endocrinology Morriston Hospital, Swansea Bay University Health Board Swansea UK

2. Institute of Life Sciences‐2 Swansea Bay University Health Board and Swansea University Medical School, Swansea University Swansea UK

3. Diabetes Research Group Swansea University Medical School, Swansea University Swansea UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14399

Reference90 articles.

1. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes